Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

BiTE

A substance made in the laboratory that can bind to two target proteins on the surface of different cells. For example, a BiTE may bind to a certain protein on healthy T cells (a type of immune cell) and, at the same time, to a different protein on cancer cells. This brings the T cells and cancer cells close together so the T cells can more effectively kill the cancer cells. Some BiTEs are being used to treat certain types of cancer, including acute lymphoblastic leukemia, multiple myeloma, lymphoma, and small cell lung cancer. They are a type of targeted therapy. Also called bispecific T-cell engager.

BiTE

Search NCI's Dictionary of Cancer Terms